- Markets
- Financial Services
- AMERISE
AMERISE
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Amerise Biosciences do?
Amradeep Industries Ltd is a specialized manufacturer of high quality construction and agricultural equipment. They are also involved in commodity trading.
Who are the competitors of Amerise Biosciences?
Amerise Biosciences major competitors are KLG Capital Services, Brijlaxmi Lease &Fin, Dharani Finance, Aravali Sec. & Fin, Futuristic Sec, Amarnath Sec., Siddha Ventures. Market Cap of Amerise Biosciences is ₹6 Crs. While the median market cap of its peers are ₹6 Crs.
Is Amerise Biosciences financially stable compared to its competitors?
Amerise Biosciences seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Amerise Biosciences pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Amerise Biosciences latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Amerise Biosciences allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances
How strong is Amerise Biosciences balance sheet?
Amerise Biosciences balance sheet is weak and might have solvency issues
Is the profitablity of Amerise Biosciences improving?
No, profit is decreasing. The profit of Amerise Biosciences is -₹0.15 Crs for Mar 2024, -₹0.12 Crs for Mar 2023 and ₹0.55 Crs for Mar 2022
Is the debt of Amerise Biosciences increasing or decreasing?
Yes, The debt of Amerise Biosciences is increasing. Latest debt of Amerise Biosciences is -₹0.02 Crs as of Sep-24. This is greater than Mar-24 when it was -₹0.03 Crs.
Is Amerise Biosciences stock expensive?
Amerise Biosciences is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Amerise Biosciences is 0.0, while 3 year average PE is -0.23. Also latest EV/EBITDA of Amerise Biosciences is 0.0 while 3yr average is 0.06.
Has the share price of Amerise Biosciences grown faster than its competition?
Amerise Biosciences has given lower returns compared to its competitors. Amerise Biosciences has grown at ~-18.8% over the last 10yrs while peers have grown at a median rate of 7.98%
Is the promoter bullish about Amerise Biosciences?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Amerise Biosciences?
There is Insufficient data to gauge this.